Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Weight-loss drugs have “little or no effect” on reducing the risk of cancers related to obesity, according to a new study.

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel nPulse™ ...

Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...

Even as incidence of several types of cancers is rising, death rate does not always rise, and that has led several ...

The study, published this week in the Annals of Internal Medicine, suggests that GLP-1s have little to no effect on a ...

Deepa Taneja, MD Florida Diabetes Thyroid & Endocrine Center ABOUT THE DOCTOR Deepa Taneja, M.D., is board-certified in ...

They're leading to reduced grocery spending, healthier food choices, wardrobe changes, and altered dining habits. The drugs ...

Weight gain or obesity is a common concern in India. While lifestyle factors, hormonal imbalances, or medications are often ...

A federal lawsuit filed on behalf of a man scheduled to be put to death next week alleges that Florida prison officials used ...

According to a new study published in the journal Frontiers in Endocrinology, researchers have found that a commonly measured ...